Richardson Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.81K Sell
35
-6
-15% -$1.29K ﹤0.01% 197
2026
Q1
$8.92K Buy
41
+35
+583% +$7.76K ﹤0.01% 218
2025
Q4
$1.37K Buy
+6
New +$1.37K ﹤0.01% 222
2025
Q2
Sell
-6
Closed -$1.26K 207
2025
Q1
$1.26K Buy
+6
New +$1.17K ﹤0.01% 220

Other funds holding ABBV

Richardson Capital Management's ABBV Position: Q2 2026 in Review

Richardson Capital Management reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $1.29K and leaving 35 shares worth $8.81K. The position accounts for ﹤0.01% of the portfolio, ranked #197.

Richardson Capital Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $8.92K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Richardson Capital Management held 35 shares of AbbVie worth $8.81K as of Q2 2026.
  • Richardson Capital Management sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up ﹤0.01% of Richardson Capital Management's portfolio in Q2 2026, its #197 holding.
  • Richardson Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Richardson Capital Management's AbbVie position peaked at $8.92K in Q1 2026.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.